Elvitegravir - CAS# 697761-98-1 nidazole InChi: InChI=1S/C16H25FN4O2/c1-16(2

InChi: InChI=1S/C16H25FN4O2/c1-16(2

K-7174 exerts anti-myeloma activity in vitro and in vivo by down-regulating the expression of class I histone deacetylases

InChi: InChI=1S/C9H9Cl2N3

InChiKey: VWVYILCFSYNJHF-UHFFFAOYSA-N

InChi: InChI=1S/C12H21N3O2/c1-2-3-4-5-6-7-8-13-10-9-11(16)15-12(17)14-10/h9H

Elvitegravir - CAS# 697761-98-1 nidazole InChi: InChI=1S/C16H25FN4O2/c1-16(2Elvitegravir, also known as GS 9137 ans EVG, is an integrase inhibitor used to treat HIV infection. The drug gained approval by the U. S. Food and Drug Administration on August 27, 2012 for use in adult patients starting HIV treatment for the first time as part of the fixed dose combination known as Stribild. Product information CAS Number: 697761 98 1 Molecular Weight: 447. 88 Formula: C23H23ClFNO5 Synonym: GS 9137 JTK 303 EVG D06677 Chemical Name: 6